HAI antikoerper, MT-SP1 antikoerper, MTSP1 antikoerper, PRSS14 antikoerper, SNC19 antikoerper, TADG15 antikoerper, TMPRSS14 antikoerper, APLP-2 antikoerper, APPH antikoerper, APPL2 antikoerper, CDEBP antikoerper, AI790698 antikoerper, Apph antikoerper, WALPLP2 antikoerper, aplp2 B antikoerper, APLP2 antikoerper, si:dkey-11k4.3 antikoerper, aplp2 A antikoerper, MGC86389 antikoerper, suppression of tumorigenicity 14 antikoerper, amyloid beta precursor like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 S homeolog antikoerper, amyloid beta (A4) precursor-like protein 2 L homeolog antikoerper, ST14 antikoerper, APLP2 antikoerper, Aplp2 antikoerper, aplp2.S antikoerper, aplp2 antikoerper, aplp2.L antikoerper
Hintergrund
This gene encodes amyloid precursor- like protein 2 (APLP2), which is a member of the APP (amyloid precursor protein) family including APP, APLP1 and APLP2. This protein is ubiquitously expressed. It contains heparin-, copper- and zinc- binding domains at the N-terminus, BPTI/Kunitz inhibitor and E2 domains in the middle region, and transmembrane and intracellular domains at the C-terminus. This protein interacts with major histocompatibility complex (MHC) class I molecules. The synergy of this protein and the APP is required to mediate neuromuscular transmission, spatial learning and synaptic plasticity. This protein has been implicated in the pathogenesis of Alzheimer's disease. Multiple alternatively spliced transcript variants encoding different isoforms have been identified.,APLP2,APLP-2,APPH,APPL2,CDEBP,Neuroscience,Neurodegenerative Diseases,Amyloid Plaque and Neurofibrillary Tangle Formation in Alzheimer's Disease,Neurodegenerative Diseases Markers,APLP2